Sale!

Nephrology Panel NGS Genetic Test Cost

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The Nephrology Panel NGS (Next-Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic variations and mutations associated with a wide range of kidney-related diseases and conditions. This advanced testing method allows for the detailed analysis of multiple genes simultaneously, providing insights into the genetic predispositions or causes of nephrological disorders. With a cost of 4400 AED, the test is aimed at facilitating early diagnosis, personalized treatment planning, and better management of kidney diseases, ultimately improving patient outcomes. DNA Labs UAE utilizes cutting-edge technology and expertise to ensure accurate and reliable results, making the Nephrology Panel NGS Genetic Test a valuable resource for patients and healthcare providers alike in the pursuit of targeted nephrology care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nephrology Panel NGS Genetic Test

About the Test

The Nephrology Panel NGS Genetic DNA Test offered by DNA Labs UAE is a comprehensive genetic test that analyzes a patient’s DNA to identify mutations or variations in genes associated with kidney diseases.

Test Components and Price

Test Name: Nephrology Panel NGS Genetic DNA Test

Components: Various genes associated with kidney diseases

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Testing Method

Next-Generation Sequencing (NGS) Technology

Test Type

Hepatology Nephrology Endocrinology Disorders

Doctor

General Physician

Test Department

Genetics

Pre-Test Information

Before undergoing the Nephrology Panel NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with various genes associated with kidney diseases, including ABCB11, ABCB4, ABCC2, ACTN4, ACVR2B, AGPS, AHI1, AIPL1, AKR1D1, ALDOB, ALG8, ALPL, ANKH, ANKS6, ANO5, ANOS1, AP2S1, ARHGAP31, ARHGDIA, ARL13B, ARL6, ARMC4, ARSL, ATP6V0A4, ATP6V1B1, ATP8B1, ATR, B9D1, B9D2, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, BCS1L, BICC1, BMP1, BMPR1B, BSND, C8orf37, CA2, CABP4, CANT1, CASP10, CASR, CC2D2A, CCDC103, CCDC114, CCDC151, CCDC28B, CCDC39, CCDC40, CCDC65, CCNO, CD2AP, CDKN1C, CENPF, CENPJ, CEP152, CEP164, CEP290, CEP41, CEP63, CFAP298, CFAP53, CFC1, CFTR, CHD7, CHSY1, CILK1, CLCN5, CLCNKA, CLCNKB, CLDN16, CLDN19, CNGA3, COL10A1, COL4A1, COL4A3, COL4A4, COL4A5, COL9A3, COMP, COQ2, COQ6, COQ8B, COQ9, CPLANE1, CRB1, CRELD1, CRTAP, CRX, CSPP1, CTNS, CUBN, CUL3, CYP7B1, DDR2, DGKE, DGUOK, DHCR7, DMP1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAL1, DRC1, DUSP6, DYM, DYNC2H1, EBP, EIF2AK3, ENPP1, ESCO2, EVC, EVC2, FAH, FAS, FASLG, FEZF1, FGF17, FGF23, FGF8, FGFR1, FKBP10, FLNB, FLRT3, FSHB, FXYD2, GDF1, GDF5, GFM1, GHR, GLA, GLI2, GLI3, GLIS2, GNA11, GNAS, GNPAT, GNRH1, GNRHR, GUCY2D, HAMP, HESX1, HEXA, HFE, HNF1B, HNF4A, HS6ST1, HSD11B2, HSD3B7, HSPG2, HYDIN, HYLS1, IFITM5, IFT122, IFT140, IFT172, IFT27, IFT43, IFT80, IL17RD, IMPDH1, INF2, INPP5E, INPPL1, INVS, IQCB1, ITGA3, JAG1, KCNJ1, KCNJ10, KCNJ13, KCNJ5, KIF7, KISS1, KISS1R, KLHL3, LAMB2, LBR, LCA5, LCT, LEFTY2, LEP, LEPR, LHB, LHX3, LHX4, LIFR, LMX1B, LRAT, LRP5, LRRC6, LZTFL1, MAGI2, MATN3, MCEE, MERTK, MKKS, MKS1, MMAA, MMAB, MMADHC, MMP13, MMP21, MMP9, MMUT, MPV17, MYH9, MYO7A, NBAS, NEK1, NEK8, NEUROG3, NKX2-5, NKX3-2, NME8, NMNAT1, NODAL, NOG, NOTCH2, NPC1, NPC2, NPHP1, NPHP3, NPHP4, NPHS1, NPHS2, NR0B1, NR0B2, NR3C2, NSDHL, NSMF, OCRL, OFD1, OTX2, P3H1, PAX2, PCSK1, PDE6D, PDSS2, PEX1, PEX10, PEX12, PEX2, PEX26, PEX5, PEX6, PEX7, PHEX, PHF6, PKD1, PKD1L1, PKD2, PKHD1, PLCE1, PLOD2, PMM2, PNPLA6, POLG, POLR3B, POMC, POU1F1, PPARG, PPIB, PRKAR1A, PROK2, PROKR2, PROM1, PROP1, PRPH2, PTH1R, RBBP8, RD3, RDH12, RDH5, RHO, RLBP1, RMND1, ROR2, RPE65, RPGRIP1, RPGRIP1L, RRM2B, RSPH1, RSPH4A, RSPH9, RUNX2, SALL1, SALL4, SBDS, SCARB2, SCNN1A, SCNN1B, SCNN1G, SDCCAG8, SEMA3A, SERPINA1, SERPINF1, SERPINH1, SLC12A1, SLC12A3, SLC25A13, SLC25A15, SLC26A2, SLC26A3, SLC2A2, SLC34A1, SLC34A3, SLC35D1, SLC4A1, SLC4A4, SLCO1B1, SLCO1B3, SMPD1, SOX10, SOX2, SOX3, SOX9, SPAG1, SPATA7, SPINT2, SPRY4, TAC3, TACR3, TBX5, TCTN1, TCTN2, TCTN3, TFR2, TJP2, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TNFRSF11B, TRIM32, TRIP11, TRMU, TRPC6, TRPS1, TRPV4, TSC1, TSC2, TTC21B, TTC8, TULP1, UGT1A1, VHL, VIPAS39, WDPCP, WDR11, WDR19, WDR34, WDR35, WDR60, WDR73, WNK1, WNK4, WNT5A, WNT7A, WT1, ZIC3, ZMYND10, ZNF423

Test Details

The Nephrology Panel NGS Genetic DNA Test is a powerful tool for diagnosing and managing kidney diseases. It utilizes next-generation sequencing (NGS) technology to analyze multiple genes associated with kidney diseases in a single test.

This test is primarily used to:

  • Diagnose inherited kidney diseases, such as polycystic kidney disease, Alport syndrome, and Fabry disease.
  • Identify genetic factors that increase the risk of developing kidney disease, including mutations in the APOL1 gene.

The results of the Nephrology Panel NGS Genetic DNA Test can provide valuable information for treatment decisions, prognosis, and identifying family members who may be at risk of developing kidney disease.

By offering a comprehensive analysis of a patient’s genetic profile, this test has the potential to improve patient outcomes and quality of life.

 

Test NameNephrology Pnael NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeHepatology Nephrology Endocrinology Disorders
DoctorGeneral Physician
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Nephrology Pnael NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCB11, ABCB4, ABCC2, ACTN4, ACVR2B, AGPS, AHI1, AIPL1, AKR1D1, ALDOB, ALG8, ALPL, ANKH, ANKS6, ANO5, ANOS1, AP2S1, ARHGAP31, ARHGDIA, ARL13B, ARL6, ARMC4, ARSL, ATP6V0A4, ATP6V1B1, ATP8B1, ATR, B9D1, B9D2, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, BCS1L, BICC1, BMP1, BMPR1B, BSND, C8orf37, CA2, CABP4, CANT1, CASP10, CASR, CC2D2A, CCDC103, CCDC114, CCDC151, CCDC28B, CCDC39, CCDC40, CCDC65, CCNO, CD2AP, CDKN1C, CENPF, CENPJ, CEP152, CEP164, CEP290, CEP41, CEP63, CFAP298, CFAP53, CFC1, CFTR, CHD7, CHSY1, CILK1, CLCN5, CLCNKA, CLCNKB, CLDN16, CLDN19, CNGA3, COL10A1, COL4A1, COL4A3, COL4A4, COL4A5, COL9A3, COMP, COQ2, COQ6, COQ8B, COQ9, CPLANE1, CRB1, CRELD1, CRTAP, CRX, CSPP1, CTNS, CUBN, CUL3, CYP7B1, DDR2, DGKE, DGUOK, DHCR7, DMP1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAL1, DRC1, DUSP6, DYM, DYNC2H1, EBP, EIF2AK3, ENPP1, ESCO2, EVC, EVC2, FAH, FAS, FASLG, FEZF1, FGF17, FGF23, FGF8, FGFR1, FKBP10, FLNB, FLRT3, FSHB, FXYD2, GDF1, GDF5, GFM1, GHR, GLA, GLI2, GLI3, GLIS2, GNA11, GNAS, GNPAT, GNRH1, GNRHR, GUCY2D, HAMP, HESX1, HEXA, HFE, HNF1B, HNF4A, HS6ST1, HSD11B2, HSD3B7, HSPG2, HYDIN, HYLS1, IFITM5, IFT122, IFT140, IFT172, IFT27, IFT43, IFT80, IL17RD, IMPDH1, INF2, INPP5E, INPPL1, INVS, IQCB1, ITGA3, JAG1, KCNJ1, KCNJ10, KCNJ13, KCNJ5, KIF7, KISS1, KISS1R, KLHL3, LAMB2, LBR, LCA5, LCT, LEFTY2, LEP, LEPR, LHB, LHX3, LHX4, LIFR, LMX1B, LRAT, LRP5, LRRC6, LZTFL1, MAGI2, MATN3, MCEE, MERTK, MKKS, MKS1, MMAA, MMAB, MMADHC, MMP13, MMP21, MMP9, MMUT, MPV17, MYH9, MYO7A, NBAS, NEK1, NEK8, NEUROG3, NKX2-5, NKX3-2, NME8, NMNAT1, NODAL, NOG, NOTCH2, NPC1, NPC2, NPHP1, NPHP3, NPHP4, NPHS1, NPHS2, NR0B1, NR0B2, NR3C2, NSDHL, NSMF, OCRL, OFD1, OTX2, P3H1, PAX2, PCSK1, PDE6D, PDSS2, PEX1, PEX10, PEX12, PEX2, PEX26, PEX5, PEX6, PEX7, PHEX, PHF6, PKD1, PKD1L1, PKD2, PKHD1, PLCE1, PLOD2, PMM2, PNPLA6, POLG, POLR3B, POMC, POU1F1, PPARG, PPIB, PRKAR1A, PROK2, PROKR2, PROM1, PROP1, PRPH2, PTH1R, RBBP8, RD3, RDH12, RDH5, RHO, RLBP1, RMND1, ROR2, RPE65, RPGRIP1, RPGRIP1L, RRM2B, RSPH1, RSPH4A, RSPH9, RUNX2, SALL1, SALL4, SBDS, SCARB2, SCNN1A, SCNN1B, SCNN1G, SDCCAG8, SEMA3A, SERPINA1, SERPINF1, SERPINH1, SLC12A1, SLC12A3, SLC25A13, SLC25A15, SLC26A2, SLC26A3, SLC2A2, SLC34A1, SLC34A3, SLC35D1, SLC4A1, SLC4A4, SLCO1B1, SLCO1B3, SMPD1, SOX10, SOX2, SOX3, SOX9, SPAG1, SPATA7, SPINT2, SPRY4, TAC3, TACR3, TBX5, TCTN1, TCTN2, TCTN3, TFR2, TJP2, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TNFRSF11B, TRIM32, TRIP11, TRMU, TRPC6, TRPS1, TRPV4, TSC1, TSC2, TTC21B, TTC8, TULP1, UGT1A1, VHL, VIPAS39, WDPCP, WDR11, WDR19, WDR34, WDR35, WDR60, WDR73, WNK1, WNK4, WNT5A, WNT7A, WT1, ZIC3, ZMYND10, ZNF423
Test Details

Nephrology panel NGS genetic DNA test is a genetic test that analyzes a patient’s DNA to identify mutations or variations in genes that are associated with kidney diseases. This test uses next-generation sequencing (NGS) technology to sequence multiple genes at once, providing a comprehensive analysis of the patient’s genetic profile.

The test is used to diagnose inherited kidney diseases, such as polycystic kidney disease, Alport syndrome, and Fabry disease. It can also help identify genetic factors that increase the risk of developing kidney disease, such as mutations in the APOL1 gene.

The results of the nephrology panel NGS genetic DNA test can help guide treatment decisions and provide information about the patient’s prognosis. It can also be used to identify family members who may be at risk of developing kidney disease.

Overall, the nephrology panel NGS genetic DNA test is a powerful tool for diagnosing and managing kidney diseases, and it has the potential to improve patient outcomes and quality of life.